Brief: Invex Therapeutics Says Got HREC And TGA Approval To Commence Phase 3 In Australia
04/07/2022 02:31
July 4 (Reuters) - Invex Therapeutics Ltd IXC.AX :
* HREC AND TGA APPROVAL TO COMMENCE PHASE 3 IN
AUSTRALIA-IXC.AX
* GOT HUMAN RESEARCH ETHICS COMMITTEE NOD & CLINICAL TRIAL
NOTIFICATION SCHEME CLEARANCE BY TGA
* APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL
IN
AUSTRALIA
Source text for Eikon: ID:nASX56Gy3x
Further company coverage: IXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invex Therapeutics
See all newsBrief: Invex Therapeutics Requests Trading Halt
Brief: Invex Therapeutics Says Narelle Warren Resigns As CFO
Brief: Invex Therapeutics' Negotiations Discontinued With Neurological Disease Therapeutics Development Co
Australia's Invex Therapeutics falls as agreement talks fade
Brief: Invex Therapeutics Seeks Trading Halt